apomorphine has been researched along with Multiple System Atrophy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dechant, G; Hainzer, M; Köllensperger, M; Nikkhah, G; Pallua, A; Poewe, W; Puschban, Z; Reindl, M; Stefanova, N; Wenning, GK | 1 |
| Döbrössy, MD; García, J; Kaindlstorfer, C; Nikkhah, G; Wenning, GK; Winkler, C | 1 |
| Aniel-Quiroga, MA; Barcena, J; Cruz Lachén, M; Gómez, JC; Hurtado, P; Lezcano, E; Pérez Bas, M; Rouco, I; Velasco, F; Zarranz, JJ | 1 |
| Köllensperger, M; Poewe, W; Reindl, M; Stefanova, N; Wenning, GK | 1 |
| Kannari, K; Maeda, T; Matsunaga, M; Suda, T | 1 |
| Beretta, S; Garavaglia, P; Manfredi, L; Pellegrini, G | 1 |
| Alesch, F; Binder, H; Helscher, RJ; Murg, M; Pinter, MM | 1 |
| Humpel, C; Levivier, M; Poewe, W; Puschban, Z; Scherfler, C; Seppi, K; Stefanova, N; Waldner, R; Wenning, GK | 1 |
| Friess, E; Holsboer, F; Kuempfel, T; Rupprecht, R; Schmid, D; Trenkwalder, C; Uhr, M; Winkelmann, J | 1 |
| Jellinger, K; Poewe, W; Puschban, Z; Scherfler, C; Seppi, K; Waldner, R; Wenning, GK | 1 |
| O'Sullivan, JD | 1 |
3 trial(s) available for apomorphine and Multiple System Atrophy
| Article | Year |
|---|---|
Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Apomorphine; Cerebral Cortex; Electromagnetic Fields; Electromyography; Evoked Potentials, Motor; Female; Humans; Male; Motor Cortex; Multiple System Atrophy; Parkinson Disease; Somatosensory Cortex | 1998 |
Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus.
Topics: Aged; Apomorphine; Electric Stimulation Therapy; Electrodes, Implanted; Female; Fingers; Forecasting; Humans; Intraoperative Care; Male; Middle Aged; Movement; Multiple System Atrophy; Parkinson Disease; Subthalamic Nucleus; Time Factors; Treatment Outcome | 1999 |
Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Apomorphine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Prolactin | 2001 |
8 other study(ies) available for apomorphine and Multiple System Atrophy
| Article | Year |
|---|---|
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response.
Topics: Analysis of Variance; Animals; Apomorphine; Brain; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Levodopa; Male; Motor Activity; Multiple System Atrophy; Random Allocation; Rats; Rats, Wistar; Transplantation, Homologous | 2009 |
Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.
Topics: Animals; Apomorphine; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Exploratory Behavior; Female; Functional Laterality; Gait Disorders, Neurologic; Motor Activity; Multiple System Atrophy; Oxidopamine; Parkinson Disease; Psychomotor Performance; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2012 |
[Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
Topics: Aged; Antiparkinson Agents; Apomorphine; Autonomic Nervous System; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Parkinson Disease | 2006 |
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy.
Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Functional Laterality; Levodopa; Male; Multiple System Atrophy; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra | 2007 |
[Reduction of apomorphine-induced rotation in rats with additional destruction of the pedunculopontine nucleus contralateral to the unilateral nigrostriatal lesion].
Topics: Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dopamine Agonists; Male; Motor Activity; Multiple System Atrophy; N-Methylaspartate; Pons; Rats; Rats, Wistar; Rotation | 1998 |
Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
Topics: Animals; Apomorphine; Autoradiography; Binding, Competitive; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Fetal Tissue Transplantation; Male; Membrane Proteins; Motor Activity; Multiple System Atrophy; Nerve Tissue Proteins; Oxidopamine; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Striatonigral Degeneration; Treatment Failure | 2000 |
No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
Topics: Animals; Apomorphine; Brain Tissue Transplantation; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Fetal Tissue Transplantation; Humans; Male; Mesencephalon; Motor Activity; Multiple System Atrophy; Neurons; Neurotoxins; Nitro Compounds; Propionates; Psychomotor Performance; Rats; Rats, Wistar; Substantia Nigra; Time Factors | 2001 |
Apomorphine as an alternative to sildenafil in Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Erectile Dysfunction; Humans; Injections, Subcutaneous; Male; Multiple System Atrophy; Parkinson Disease; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2002 |